The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

被引：50
|
作者：
Khezri, Mohammad Rafi [1 ]
Jafari, Reza [2 ]
Yousefi, Keyvan [3 ]
Zolbanin, Naime Majidi [4 ,5 ,6 ]
机构：
[1] Urmia Univ Med Sci, Student Res Comm, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Cellular & Mol Med Inst, Cellular & Mol Res Ctr, Orumiyeh, Iran
[3] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33146 USA
[4] Urmia Univ Med Sci, Expt & Appl Pharmaceut Sci Res Ctr, Orumiyeh, Iran
[5] Urmia Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Orumiyeh, Iran
[6] Urmia Univ Med Sci, Sch Fac Pharm, Dept Pharmacol & Toxicol, Sero Rd, Orumiyeh, Iran
来源：
EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2022年 / 127卷
关键词：
Angiogenesis; Apoptosis; Cancer; PI3K; AKT; CELL LUNG-CANCER; INHIBITS TUMOR ANGIOGENESIS; GROWTH-FACTOR RECEPTOR; I KAPPA B; BREAST-CANCER; GASTRIC-CANCER; OVARIAN-CANCER; PANCREATIC-CANCER; UP-REGULATION; COLON-CANCER;
D O I：
10.1016/j.yexmp.2022.104787
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
The human body consists of countless cells with the possibility of excessive and uncontrolled proliferation under certain dysregulated circumstances that could cause abnormal states such as cancer. Phosphatidylinositol 3 kinase (PI3K) and its downstream target, Protein kinase B or AKT, play a critical role in cell survival, proliferation, differentiation, migration, and metabolism. Research studies have examined the aberrant expression of signaling molecules that regulate PI3K/AKT pathway with the purpose of target discovery. The present review aims to recapitulate the relationship between the PI3K/AKT signaling pathway and factors contributing to initiation and development of various cancers. In addition, therapeutic interventions regulating this signaling pathway have been summarized.
引用
收藏
页数：12
相关论文
共 50 条
  • [41] The PI3K/AKT/mTOR signaling pathway: Implications in the treatment of breast cancer
    Andreopoulou E.
    Current Breast Cancer Reports, 2011, 3 (1) : 63 - 74
  • [42] Marine compounds targeting the PI3K/Akt signaling pathway in cancer therapy
    Wei, Jiaen
    Gou, Zhanping
    Wen, Ying
    Luo, Qiaohong
    Huang, Zunnan
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [43] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    Antonino Glaviano
    Aaron S. C. Foo
    Hiu Y. Lam
    Kenneth C. H. Yap
    William Jacot
    Robert H. Jones
    Huiyan Eng
    Madhumathy G. Nair
    Pooyan Makvandi
    Birgit Geoerger
    Matthew H. Kulke
    Richard D. Baird
    Jyothi S. Prabhu
    Daniela Carbone
    Camilla Pecoraro
    Daniel B. L. Teh
    Gautam Sethi
    Vincenzo Cavalieri
    Kevin H. Lin
    Nathalie R. Javidi-Sharifi
    Eneda Toska
    Matthew S. Davids
    Jennifer R. Brown
    Patrizia Diana
    Justin Stebbing
    David A. Fruman
    Alan P. Kumar
    Molecular Cancer, 22
  • [44] Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
    Akbarzadeh, Maryam
    Mihanfar, Ainaz
    Akbarzadeh, Shabnam
    Yousefi, Bahman
    Majidinia, Maryam
    LIFE SCIENCES, 2021, 285
  • [45] Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway
    Yang, Jing
    Ren, Xianyue
    Zhang, Liping
    Li, Yuanyuan
    Cheng, Bin
    Xia, Juan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 100 : 226 - 232
  • [46] Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review)
    Shi, Xiang
    Wang, Jingjing
    Lei, Yu
    Cong, Caofan
    Tan, Dailin
    Zhou, Xianrong
    MOLECULAR MEDICINE REPORTS, 2019, 19 (06) : 4529 - 4535
  • [47] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    Glaviano, Antonino
    Foo, Aaron S. C.
    Lam, Hiu Y.
    Yap, Kenneth C. H.
    Jacot, William
    Jones, Robert H.
    Eng, Huiyan
    Nair, Madhumathy G.
    Makvandi, Pooyan
    Geoerger, Birgit
    Kulke, Matthew H.
    Baird, Richard D.
    Prabhu, Jyothi S.
    Carbone, Daniela
    Pecoraro, Camilla
    Teh, Daniel B. L.
    Sethi, Gautam
    Cavalieri, Vincenzo
    Lin, Kevin H.
    Javidi-Sharifi, Nathalie R.
    Toska, Eneda
    Davids, Matthew S.
    Brown, Jennifer R.
    Diana, Patrizia
    Stebbing, Justin
    Fruman, David A.
    Kumar, Alan P.
    MOLECULAR CANCER, 2023, 22 (01)
  • [48] Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
    Xue, Chen
    Li, Ganglei
    Lu, Juan
    Li, Lanjuan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [49] Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
    Stanciu, Silviu
    Ionita-Radu, Florentina
    Stefani, Constantin
    Miricescu, Daniela
    Stanescu-Spinu, Iulia-Ioana
    Greabu, Maria
    Totan, Alexandra Ripszky
    Jinga, Mariana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [50] PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
    Miricescu, Daniela
    Totan, Alexandra
    Stanescu-Spinu, Iulia-Ioana
    Badoiu, Silviu Constantin
    Stefani, Constantin
    Greabu, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 24
12345